Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
1,069.00
-11.00 (-1.02%)
Sep 8, 2026, 5:24 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 122.02 million as of September 8, 2026. Its market cap has decreased by -9.79% in one year.
Market Cap
122.02M
Enterprise Value
237.26M
Revenue
304.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,069.00
ChartMarket Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 122.02M, an increase of 13.07%. That is a compound annual growth rate of 0.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 122.02M | -2.29% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 127.56B |
| Danel (Adir Yeoshua) | 2.62B |
| Amal Holdings A.D. | 2.30B |
| BrainsWay | 1.70B |
| Bonus BioGroup | 210.26M |
| InterCure | 196.88M |
| Golden House | 171.92M |
| Matricelf | 90.85M |